RxDoctor Payments Data

Katelyn Holder

Physician Assistant · South Boston, VANPI 1033743299

Payments from drug & device makers

$3,387in general payments, 2019–2025

Across 213 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$444
  • AstraZeneca$410
  • Bayer$400
  • Otsuka America Pharmaceutical, Inc.$319
  • Ardelyx, Inc.$254
  • Vifor Pharma, Inc.$243
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,03990%
  • Education$3159%
  • Other$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,387 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$61,350
Medicare patients
287
Services billed
1,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol168$140,653
XphozahTenapanor Hcl20$105,249
AuryxiaFerric Citrate37$71,726
JardianceEmpagliflozin54$45,383
VelphoroSucroferric Oxyhydroxide17$41,878
VeltassaPatiromer Calcium Sorbitex31$34,752
OzempicSemaglutide13$19,791
RenvelaSevelamer Carbonate11$19,751
Sevelamer Carbonate122$18,653
LokelmaSodium Zirconium Cyclosilicate17$11,524
DapagliflozinDapagliflozin Propanediol13$6,594
Valsartan150$2,382
Tamsulosin Hcl80$766
Labetalol Hcl34$741
Albuterol Sulfate HfaAlbuterol Sulfate18$665

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$410$152,176185 claims
Akebia Therapeutics IncAuryxia$144$71,72637 claims
Boehringer IngelheimJardiance$107$45,38354 claims
Fresenius USA Marketing, Inc.Velphoro$28$41,87817 claims
Novo NordiskOzempic$81$19,79113 claims
ANI Pharmaceuticals, Inc.Valsartan$51$2,382150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in South Boston

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →